NCT03748459

Brief Summary

Traditional suture closure of the columellar scar in rhinoplasty is achieved with permanent skin sutures. These sutures create less inflammation and are thought to lead to improved final scar outcomes. However, permanent sutures require removal which creates pain and inconvenience for the patient. Some surgeons use fast absorbing sutures that do not require removal. The difference in final scar outcome based on suture material used has not been well studied. This study will examine the final scar outcomes of rhinoplasty incisions sutured with traditional permanent suture compared to fast absorbing suture. If scar outcomes are similar between these groups as judged by the patients and blinded observers, rhinoplasty surgeons may be able to preferentially utilize absorbable sutures for incision closure and avoid the pain and inconvenience for the patient during suture removal

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2017

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 7, 2017

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

November 19, 2018

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 20, 2018

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 14, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 14, 2020

Completed
Last Updated

September 4, 2024

Status Verified

August 1, 2024

Enrollment Period

2.8 years

First QC Date

November 19, 2018

Last Update Submit

August 30, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Patient Scar Assessment

    Patient scar assessment will be done with a patient completed questionnaire. The questionnaire is a validated scar assessment instrument for self rating of surgical scars by patients for a minimum rating of 28 (best scar) to 112 (worst scar)

    12 months after surgery

  • Clinician Scar Assessment

    Clinician scar assessment will be done using photographs of the scar 12 months after surgery. Clinicians will use a validated clinician scar grading tool for evaluation of surgical scars with a range of 0 (worst scar) to 5 (best scar)

    12 months after surgery

Study Arms (2)

Permanent suture

Subjects will have skin closure with permanent suture (prolene) (6-0 polypropylene) in open rhinoplasty.

Other: Closure with Permanent Suture

Resorbable suture

Subjects will have skin closure with Resorbable Suture (5-0 fast absorbing plain gut) in open rhinoplasty

Other: Closure with Resorbable Suture

Interventions

Skin closure with permanent suture (prolene) (6-0 polypropylene) in open rhinoplasty.

Permanent suture

Skin closure with Resorbable Suture (5-0 fast absorbing plain gut) in open rhinoplasty.

Resorbable suture

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult patients seeking rhinoplasty surgery with one of the investigators.

You may qualify if:

  • Adult (age ≥ 18 years) patients undergoing primary open rhinoplasty surgery for any reason with any of the study surgeons.

You may not qualify if:

  • Patients undergoing rhinoplasty for cleft nasal deformity or nasal reconstruction related to cancer resection
  • Patients with previous surgery that involved a columellar incision. Patients with history of previous nasal surgery that did not involve an incision on the columella may be included
  • Patients with known history of cutaneous disorder that affects scaring such as personal history of keloid formation, collagen vascular disease, or previous radiation to the surgical site
  • Inability or unwillingness of subject to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Medical University of South Carolina

Charleston, South Carolina, 29425, United States

Location

Ralph Johnson VA Medical Center

Charleston, South Carolina, 29425, United States

Location

MeSH Terms

Conditions

Surgical Wound

Condition Hierarchy (Ancestors)

Wounds and Injuries

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 19, 2018

First Posted

November 20, 2018

Study Start

December 7, 2017

Primary Completion

September 14, 2020

Study Completion

September 14, 2020

Last Updated

September 4, 2024

Record last verified: 2024-08

Locations